ATP1A3 as a target for isolating neuron-specific extracellular vesicles from human brain and biofluids.

Yuka A Martens, Takahisa Kanekiyo, Yang You, Zhengrong Zhang, Nadia Sultana, Maria Ericsson, Min Sun, Seiko Ikezu, Scott A Shaffer, Tsuneya Ikezu

Journal: Science advances 2023;9(37):eadi3647

PMID: 37713494

Abstract

Neuron-derived extracellular vesicles (NDEVs) are potential biomarkers of neurological diseases although their reliable molecular target is not well established. Here, we demonstrate that ATPase Na/K transporting subunit alpha 3 (ATP1A3) is abundantly expressed in extracellular vesicles (EVs) isolated from induced human neuron, brain, cerebrospinal fluid, and plasma in comparison with the presumed NDEV markers NCAM1 and L1CAM by using super-resolution microscopy and biochemical assessments. Proteomic analysis of immunoprecipitated ATP1A3 brain-derived EVs shows higher enrichment of synaptic markers and cargo proteins relevant to Alzheimer's disease (AD) compared to NCAM1 or LICAM EVs. Single particle analysis shows the elevated amyloid-β positivity in ATP1A3 EVs from AD plasma, providing better diagnostic prediction of AD over other plasma biomarkers. Thus, ATP1A3 is a reliable target to isolate NDEV from biofluids for diagnostic research.

Address: Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.; Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.; Mass Spectrometry Facility, University of Massachusetts Chan Medical School, Shrewsbury, MA USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.; Nanoview Biosciences, Boston, MA, USA School, Boston, MA, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.